Cellectar Biosciences, Inc. (CLRB) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cellectar Biosciences, Inc. on June 18, 2025. The report discloses a corporate action approved by stockholders at the annual meeting held on June 13, 2025, and finalized by the Board of Directors.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the structural change to the company's capitalization.
Material Changes
- Reverse Stock Split: The Board approved a one-for-thirty (1:30) reverse stock split of the Company's common stock.
- Effective Date: The split will become effective at 12:01 a.m. Eastern Time on Tuesday, June 24, 2025.
- Share Conversion: Every 30 shares of common stock issued and outstanding as of the Effective Time will be converted into one share.
- Fractional Shares: Stockholders entitled to fractional shares will receive a cash payment in lieu of such shares.
- Adjustments to Securities:
- Equity incentive plan share availability will be proportionately adjusted.
- Outstanding stock options and warrants will have their share counts divided by 30 and exercise/conversion prices multiplied by 30, maintaining the same aggregate exercise price.
- Conversion ratios for outstanding preferred stock will adjust proportionately.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the mechanics of the stock split. The primary purpose is to notify the market of the impending change in share structure.
Investor Verification Checklist
- Verify the exact number of shares held prior to June 24, 2025, to calculate post-split holdings.
- Confirm the cash payment amount for any fractional shares resulting from the 1:30 ratio.
- Review the adjusted exercise prices and share counts for any held stock options or warrants.
- Monitor the Nasdaq Capital Market for the trading symbol and price adjustments effective June 24, 2025.